Clinical Trial Update: First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

First-in-human Phase 1/2 trial update of STC-1010 immunotherapy for unresectable locally advanced or metastatic colorectal cancer, sponsored by Brenus Pharma, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• STC-1010

Snippet

Sponsor: Brenus Pharma | Conditions: Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer | Phase 1, Phase 2 | Status: RECRUITING